Primary Sclerosing Cholangitis Associated with Elevated Immunoglobulin-G4: A Preliminary Study

Table 2

Demographic clinical, and laboratory features in the IAC patients. Laboratory parameters are demonstrated as median and IQR.

	Patients with PSC with IgG4 elevation (IAC) (𝑛=9)
Age, years	45 (21–60)
Gender (male)	7 (77.8%)
Smoking	4 (44.4%)
IBD Present	3 (33.3%)
High CA 19-9	7 (77.8%)
AMA (±)	0
ASMA (±)	1 (11.1%)
ALKM (±)	0
Intrahepatic involvement (MRCP)	5 (55.6%)
Extrahepatic involvement (MRCP)	1 (11.1%)
IgG4 (10–157 mg/dL)	218.00±46.33; (159–292 mg/dL)
Hb	12.58±1.87 (8–14.4)
AST (<40 U/L)	75.44±51.85 (27–160)
ALT (<40 U/L)	69.88±51.08 (19–160)
Alk Ph (<200 U/L)	664.11±328.29 (327–1436)
Bil total (<2 mg/dL)	2.82±2.53 (0.4–6.90)
Bil direct (<2 mg/dL)	1.84±2.21 (0.1–5.8)